Apollomics Inc. (APLM)
NASDAQ: APLM
· Real-Time Price · USD
6.36
-0.05 (-0.83%)
At close: Jun 27, 2025, 3:59 PM
6.51
2.36%
After-hours: Jun 27, 2025, 04:00 PM EDT
-0.83% (1D)
| Bid | 6.05 |
| Market Cap | 7.02M |
| Revenue (ttm) | 2.27M |
| Net Income (ttm) | -57.11M |
| EPS (ttm) | -52.8 |
| PE Ratio (ttm) | -0.12 |
| Forward PE | -0.05 |
| Analyst | Buy |
| Ask | 6.86 |
| Volume | 8,295 |
| Avg. Volume (20D) | 24,041 |
| Open | 6.62 |
| Previous Close | 6.41 |
| Day's Range | 6.26 - 6.70 |
| 52-Week Range | 4.47 - 36.00 |
| Beta | 0.88 |
About APLM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol APLM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for APLM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
-10.58%
Apollomics shares are trading lower. The company r...
Unlock content with
Pro Subscription
2 months ago
-18.53%
Apollomics shares are trading higher after the company announced a development and commercialization agreement for Vebreltinib.
